Evidence map›Paper›PMID 38778615›Full record

ArticleCurrent drug delivery2025

Three-Dimensional Printing Technology for Medicines.

Clara Dias de Castro Moreira da Silva, Ana Paula Dos Santos Matos, Beatriz Hecht Ortiz, Alessandra Lifsitch Vicosa, Eduardo Ricci-Junior

Abstract readEditorial
PubMed Publisher
In one paragraph

Article in Current drug delivery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Clara Dias de Castro Moreira da SilvaPharmaceutical Nanotechnology Laboratory, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro-RJ, Brazil.
Ana Paula Dos Santos MatosFarmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
Beatriz Hecht OrtizFarmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
Alessandra Lifsitch VicosaFarmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
Eduardo Ricci-JuniorPharmaceutical Nanotechnology Laboratory, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro-RJ, Brazil.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 309790/2023-9Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) E-26/201.077/2021, E-26/210.136/2021
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

3D printingadherence to treatmentcustomized medicinedrug deliveryindividualized doseprinted medicine

Identifiers

PMID38778615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.